San Diego, CA, United States of America

Michael Siu

This inventor holds 1 USPTO granted patent. Top assignees: Agouron Pharmaceuticals, Inc., Pfizer Corporation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Siu. Retrieved from https://idiyas.com/inventor/michael-siu-b3ql2let

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Siu: Innovator in Pharmaceutical Chemistry

Introduction

Michael Siu is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.

Latest Patents

One of Michael Siu's key patents is for N-(pyridin-2-yl)-sulfonamide derivatives. This invention relates to novel compounds and pharmaceutical compositions that include these compounds, their pharmaceutically acceptable salts, hydrates, and solvates. The compounds are designed for use in medicine, specifically targeting the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme (11βHSD1).

Career Highlights

Throughout his career, Michael Siu has worked with prominent companies in the pharmaceutical industry, including Agouron Pharmaceuticals, Inc. and Pfizer Corporation. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Michael has collaborated with several professionals in his field, including Sajiv Krishnan Nair and Wendy Dianne Taylor. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Michael Siu's contributions to pharmaceutical chemistry and his innovative patent work demonstrate his commitment to advancing medical science. His achievements reflect the importance of collaboration and innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…